Although the vision of the learning health system is simple in theory, it is highly complicated, said Penny Mohr, senior program officer for improving healthcare systems at the Patient-Centered Outcomes Research Institute, during the first plenary session at the ISPOR 20th Annual Meeting, held May 18-20 in Philadelphia, Pennsylvania.
Although the vision of the learning health system is simple in theory, it is highly complicated, said Penny Mohr, senior program officer for improving healthcare systems at the Patient-Centered Outcomes Research Institute (PCORI), during the first plenary session at the ISPOR 20th Annual Meeting, held May 18-20 in Philadelphia, Pennsylvania.
Ms Mohr, the program committee co-chair for the meeting, moderated the plenary session “Taking Stock of the Learning Health Care System: What Have We Achieved & Why Does It Matter?” which included panelists Sarah Greene, MPH, associate director of comparative effectiveness research methods and infrastructure at PCORI; Lewis G. Sandy, MD, FACP, senior vice president of clinical advancement at UnitedHealth Group; and Sachin H. Jain, MD, MBA, chief medical officer at CareMore/Anthem and lecturer in healthcare policy at Harvard Medical School.
In the learning healthcare system, efforts are made to learn from every clinical encounter and findings are implemented to improve patient care, explained Ms Mohr, and she identified the 3 major pillars: evidence-based, value-driven, and patient-centered care.
PCORnet and Valuing Research
The healthcare industry needs a more crystal clear understanding of the factors important to patients, clinicians, and health systems and where they align, so the learning healthcare system can be treated as a competitive advantage, said Ms Greene.
“One challenge that we have to consider here is the patients may not want to be part of a learning healthcare system … maybe they want to be part of a health system that knows,” Ms Greene said.
She also took the time speak about PCORnet, which is less than a year-and-a-half old. The goal of PCORnet is to create a different research infrastructure through things like using very pragmatic trial designs that close the gap between research and real-world context, and primarily using electronic health record data rather than claims data.
Ms Green identified the 6 points that make research easier through PCORnet:
“After about a year plus we are somewhere between learning and change,” she said.
An Important Vision With Spotty Implementation
Dr Sandy offered a look at what is going on in the healthcare system and what stakeholders actually want. He examined a set of imperatives to create a learning health system: improve the value of healthcare delivery; reduce waste; promote high-value innovation; and make the system easier for everyone.
However, the current state of healthcare in the US has a large amount of waste and a high variation in quality of care delivered.
“What we see is with this level of waste and this level of variation, purchasers—both public and private—are demanding action,” he said. “They’re coming to [payers] … and saying, ‘make it better.’”
While the implementation of the Affordable Care Act has begun a transformation of healthcare in the US through a number of payment and delivery reforms, but Dr Sandy admits being unimpressed with the transformation happening so far. What he has witnessed mostly, has been health systems focusing on transforming operations, not learning.
"Learning health systems are an important vision ... but with spotty implementation," he said.
The Pace of Change
Although the healthcare industry has convinced itself that change is slow, Dr Jain argues that does not have to be true.
“In many ways it’s the best of times for those of us interested in launching a learning healthcare system,” he said. “Today there’s a broad recognition of our deep quality problems and the long road ahead to improve them.”
However, he worries that most of the change he has seen in health companies and health systems has been small and unambitious. Building a learning health system means studying the science of health delivery to better understand the nuance associated with implementing interventions at sale.
“We must push forward our vision for the learning healthcare system because it is the right and ethical thing to do for patients,” he said.
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More